全基因组关联研究识别出与欧洲裔美国人阿片依赖相关的RGMA调控变异
在3058名暴露于阿片类药物的欧洲裔美国人中开展阿片依赖全基因组关联研究,其中1290人符合DSM-IV阿片依赖诊断。四队列荟萃分析发现15号染色体RGMA附近变异rs12442183与阿片依赖相关(p=1.3×10-8),并在非洲裔美国人中获支持,首次揭示RGMA与阿片依赖的关联。
要点
- rs12442183 near RGMA was genome-wide significant for opioid dependence in European Americans.
- Risk allele rs12442183*T correlated with higher RGMA transcript variant expression in frontal cortex.
- Findings suggest RGMA as a new lead into opioid dependence pathophysiology.
核心结论
- 首次证明RGMA与阿片依赖存在关联,为理解其病理生理提供新线索。
研究设计与样本
- 在3058名暴露于阿片类药物的欧洲裔美国人中开展阿片依赖全基因组关联研究,其中1290人符合DSM-IV阿片依赖诊断,分析采用DSM-IV标准计数。
- 对四个队列进行荟萃分析:Yale-Penn 1(n=1388)、Yale-Penn 2(n=996)、Yale-Penn 3(n=98)和SAGE(n=576)。
- 在三个队列的2014名暴露于阿片类药物的非洲裔美国人(1106人符合DSM-IV阿片依赖标准)中进行荟萃分析。
主要发现
- 四队列荟萃分析识别出15号染色体RGMA附近的rs12442183与阿片依赖相关(p=1.3×10-8)。
- 该关联在Yale-Penn 1单独分析中亦达全基因组显著性,并在其他三个样本中的两个中呈名义显著。
- 在非洲裔美国人荟萃分析中获支持(p=3.0×10-3),其中两个样本呈名义显著。
- 在两个人群共七个亚样本中,一个达全基因组显著,六个中有四个呈名义或接近名义显著。
- 风险等位基因rs12442183*T与额叶皮层特定RGMA转录变体表达升高相关(p=2×10-3)。
关键数值与推荐
- 全基因组关联研究以DSM-IV阿片依赖诊断为标准,分析采用DSM-IV标准计数。
- 欧洲裔美国人四队列荟萃分析中rs12442183与阿片依赖关联p=1.3×10-8。
- 非洲裔美国人三队列荟萃分析中关联p=3.0×10-3。
- 风险等位基因rs12442183*T与额叶皮层RGMA转录变体表达相关p=2×10-3。
临床怎么用
- RGMA及其调控变异可作为阿片依赖病理生理研究的新候选靶点。
- 风险等位基因与RGMA转录变体表达相关,提示调控机制可能参与阿片依赖。
- 慢性吗啡注射后小鼠同源基因Rgma在C57BL/6J纹状体上调,支持跨物种功能线索。
局限性
- 非洲裔美国人样本中关联仅达名义显著(p=3.0×10-3),未达全基因组显著性。
- 欧洲裔美国人其他三个样本中仅两个呈名义显著,结果需独立样本验证。
- 研究为关联分析,未直接证明RGMA变异与阿片依赖的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid dependence (OD) is at epidemic levels in the United States. Genetic studies can provide insight into its biology. METHODS: We completed an OD genome-wide association study in 3058 opioid-exposed European Americans, 1290 of whom met criteria for a DSM-IV diagnosis of OD. Analysis used DSM-IV criterion count. RESULTS: By meta-analysis of four cohorts, Yale-Penn 1 (n = 1388), Yale-Penn 2 (n = 996), Yale-Penn 3 (n = 98), and SAGE (Study of Addiction: Genetics and Environment) (n = 576), we identified a variant on chromosome 15, rs12442183, near RGMA, associated with OD (p = 1.3 × 10-8). The association was also genome-wide significant in Yale-Penn 1 taken individually and nominally significant in two of the other three samples. The finding was further supported in a meta-analysis of all available opioid-exposed African Americans (n = 2014 [1106 meeting DSM-IV OD criteria]; p = 3.0 × 10-3) from three cohorts; there was nominal significance in two of these samples. Thus, of seven subsamples examined in two populations, one was genome-wide significant, and four of six were nominally (or nearly) significant. RGMA encodes repulsive guidance molecule A, which is a central nervous system axon guidance protein. Risk allele rs12442183*T was correlated with higher expression of a specific RGMA transcript variant in frontal cortex (p = 2 × 10-3). After chronic morphine injection, the homologous mouse gene (Rgma) was upregulated in C57BL/6J striatum. Coexpression analysis of 1301 brain samples revealed that RGMA messenger RNA expression was associated with that of four genes implicated in other psychiatric disorders, including GRIN1. CONCLUSIONS: This is the first study to demonstrate an association of RGMA with OD. It provides a new lead into our understanding of OD pathophysiology.
引用
- Cheng Z, Zhou H, Sherva R, et al. Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans. Biol Psychiatry. 2018. PMID: 29478698. doi:10.1016/j.biopsych.2017.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。